Linda Palczuk - Sep 15, 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Stock symbol
AVDL
Transactions as of
Sep 15, 2024
Transactions value $
$0
Form type
4
Date filed
9/16/2024, 05:18 PM
Previous filing
Aug 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Gift $0 -11K -100% $0.00 0 Sep 15, 2024 Ordinary Shares 11K $16.32 Direct F1
holding AVDL Stock Option (Right to Buy) 11K Sep 15, 2024 Ordinary Shares 11K $16.32 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant (July 30, 2024), subject to the Reporting Person's continued service at such time.
F2 On September 15, 2024, the Reporting Person transferred 11,000 options to a revocable trust of which the Reporting Person is trustee.